FI915148A - Indol- och bensimidazolsubstituerade imidazol- och bensimidazolderivat. - Google Patents
Indol- och bensimidazolsubstituerade imidazol- och bensimidazolderivat. Download PDFInfo
- Publication number
- FI915148A FI915148A FI915148A FI915148A FI915148A FI 915148 A FI915148 A FI 915148A FI 915148 A FI915148 A FI 915148A FI 915148 A FI915148 A FI 915148A FI 915148 A FI915148 A FI 915148A
- Authority
- FI
- Finland
- Prior art keywords
- och
- bensimidazole
- bensimidazolderivat
- indol
- imidazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60663190A | 1990-10-31 | 1990-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI915148A0 FI915148A0 (fi) | 1991-10-31 |
FI915148A true FI915148A (fi) | 1992-05-01 |
Family
ID=24428787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI915148A FI915148A (fi) | 1990-10-31 | 1991-10-31 | Indol- och bensimidazolsubstituerade imidazol- och bensimidazolderivat. |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0488532A1 (fi) |
JP (1) | JPH0592969A (fi) |
KR (1) | KR920008032A (fi) |
CN (1) | CN1061224A (fi) |
AU (1) | AU650294B2 (fi) |
CA (1) | CA2054594A1 (fi) |
CS (1) | CS330591A3 (fi) |
EG (1) | EG19826A (fi) |
FI (1) | FI915148A (fi) |
HU (1) | HU214575B (fi) |
IE (1) | IE913785A1 (fi) |
IL (1) | IL99917A0 (fi) |
MX (1) | MX9101873A (fi) |
MY (1) | MY108611A (fi) |
NO (1) | NO180749C (fi) |
NZ (1) | NZ240383A (fi) |
PH (1) | PH31175A (fi) |
PL (1) | PL168902B1 (fi) |
PT (1) | PT99404A (fi) |
RO (1) | RO109735B1 (fi) |
RU (1) | RU2111208C1 (fi) |
YU (1) | YU173791A (fi) |
ZA (1) | ZA918688B (fi) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
GB9113626D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic compounds |
GB9113628D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic derivatives |
KR0156948B1 (ko) * | 1992-03-25 | 1998-11-16 | 가와노 다께히꼬 | 이소인다졸 화합물 |
DK40192D0 (da) * | 1992-03-26 | 1992-03-26 | Neurosearch As | Imidazolforbindelser, deres fremstilling og anvendelse |
US5538973A (en) * | 1992-03-27 | 1996-07-23 | Kyoto Pharmaceutical Industries, Ltd. | Imidazole derivative, pharmaceutical use thereof, and intermediate therefor |
AU658729B2 (en) * | 1992-03-27 | 1995-04-27 | Kyoto Pharmaceutical Industries, Ltd. | 3-(1H-imidazol-1-ylmethyl)-1H-indole derivatives |
GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
AU675484B2 (en) * | 1993-03-24 | 1997-02-06 | Neurosearch A/S | Benzimidazole compounds, their use and preparation |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
CN101006053A (zh) | 2004-06-18 | 2007-07-25 | 比奥里波克斯公司 | 用于治疗炎症的吲哚 |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
BRPI0511834A (pt) | 2004-07-14 | 2008-01-08 | Ptc Therapeutics Inc | métodos por tratar hepatite c |
AU2005275182A1 (en) | 2004-07-22 | 2006-02-23 | Ptc Therapeutics, Inc. | Thienopyridines for treating Hepatitis C |
ATE501119T1 (de) | 2005-01-19 | 2011-03-15 | Biolipox Ab | Entzündungshemmende indol-derivate |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CN103965167A (zh) * | 2013-01-29 | 2014-08-06 | 通化济达医药有限公司 | 咪唑羧酸衍生物 |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
AU2014274812B2 (en) | 2013-06-05 | 2018-09-27 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
CN106397414A (zh) * | 2015-08-14 | 2017-02-15 | 陈志龙 | 杂螺环酮吲哚衍生物的一种制备方法 |
CN113999204B (zh) * | 2021-11-08 | 2023-09-05 | 常州大学 | 一种非手性咪唑型离子化合物及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4826862A (en) * | 1988-02-12 | 1989-05-02 | Janssen Pharmaceutica, N.V. | Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates |
GB8820231D0 (en) * | 1988-08-25 | 1988-09-28 | Fujisawa Pharmaceutical Co | New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same |
PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
DE4010797A1 (de) * | 1990-04-04 | 1991-10-10 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
-
1991
- 1991-10-23 PH PH43330A patent/PH31175A/en unknown
- 1991-10-29 NZ NZ240383A patent/NZ240383A/en unknown
- 1991-10-30 NO NO914263A patent/NO180749C/no unknown
- 1991-10-30 EG EG66391A patent/EG19826A/xx active
- 1991-10-30 RU SU5010095A patent/RU2111208C1/ru active
- 1991-10-30 IE IE378591A patent/IE913785A1/en not_active Application Discontinuation
- 1991-10-30 HU HU913418A patent/HU214575B/hu not_active IP Right Cessation
- 1991-10-30 RO RO148651A patent/RO109735B1/ro unknown
- 1991-10-31 CN CN91110565A patent/CN1061224A/zh active Pending
- 1991-10-31 CA CA002054594A patent/CA2054594A1/en not_active Abandoned
- 1991-10-31 KR KR1019910019254A patent/KR920008032A/ko active IP Right Grant
- 1991-10-31 FI FI915148A patent/FI915148A/fi unknown
- 1991-10-31 ZA ZA918688A patent/ZA918688B/xx unknown
- 1991-10-31 AU AU86910/91A patent/AU650294B2/en not_active Ceased
- 1991-10-31 MY MYPI9102106 patent/MY108611A/xx unknown
- 1991-10-31 IL IL99917A patent/IL99917A0/xx unknown
- 1991-10-31 PT PT99404A patent/PT99404A/pt not_active Application Discontinuation
- 1991-10-31 JP JP3286584A patent/JPH0592969A/ja active Pending
- 1991-10-31 EP EP91310076A patent/EP0488532A1/en not_active Ceased
- 1991-10-31 PL PL91292249A patent/PL168902B1/pl unknown
- 1991-10-31 CS CS913305A patent/CS330591A3/cs unknown
- 1991-10-31 MX MX9101873A patent/MX9101873A/es not_active IP Right Cessation
- 1991-10-31 YU YU173791A patent/YU173791A/sh unknown
Also Published As
Publication number | Publication date |
---|---|
PL168902B1 (pl) | 1996-05-31 |
KR920008032A (ko) | 1992-05-27 |
RO109735B1 (ro) | 1995-05-30 |
PT99404A (pt) | 1992-09-30 |
AU650294B2 (en) | 1994-06-16 |
HU913418D0 (en) | 1992-01-28 |
RU2111208C1 (ru) | 1998-05-20 |
NO180749C (no) | 1997-06-11 |
NO914263L (no) | 1992-05-04 |
EP0488532A1 (en) | 1992-06-03 |
NO180749B (no) | 1997-03-03 |
CA2054594A1 (en) | 1992-05-01 |
NO914263D0 (no) | 1991-10-30 |
MY108611A (en) | 1996-10-31 |
IE913785A1 (en) | 1992-05-22 |
PH31175A (en) | 1998-03-20 |
ZA918688B (en) | 1992-08-26 |
JPH0592969A (ja) | 1993-04-16 |
CS330591A3 (en) | 1992-06-17 |
FI915148A0 (fi) | 1991-10-31 |
HUT59677A (en) | 1992-06-29 |
MX9101873A (es) | 1992-06-05 |
YU173791A (sh) | 1994-01-20 |
IL99917A0 (en) | 1992-08-18 |
EG19826A (en) | 1996-03-31 |
HU214575B (hu) | 1998-04-28 |
PL292249A1 (en) | 1992-07-13 |
CN1061224A (zh) | 1992-05-20 |
NZ240383A (en) | 1994-12-22 |
AU8691091A (en) | 1992-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI915148A (fi) | Indol- och bensimidazolsubstituerade imidazol- och bensimidazolderivat. | |
FI912703A0 (fi) | Vaesentlig fettsyrabehandling. | |
DE69112037D1 (de) | Waferträger. | |
FI914843A (fi) | Submarint produktionssystem. | |
DE69111876D1 (de) | Ophthalmometer. | |
FI86244B (fi) | Bakugn-spisugnkombination. | |
FI86263B (fi) | Skaer- och slipanordning foer en glasskivkant. | |
FI87009B (fi) | Skovelhjul foer centrifugalpumpar. | |
FI900062A (fi) | Spelanordning. | |
DE69110728D1 (de) | 8-Sulfamylmethylen-2-aminotetraline. | |
FI900028A0 (fi) | Belaeggningsmaterial. | |
DE69104797T2 (de) | 2-Substituierte-1-Hydroxyindole. | |
FI902305A0 (fi) | Laddningssystem. | |
FI900061A0 (fi) | Spelanordning. | |
FI900060A0 (fi) | Vinstfoerdelningsport foer en spelanordning. | |
ES1015245Y (es) | Traca mejorada. | |
ES1014027Y (es) | Anillo-reten mejorado. | |
ES1013945Y (es) | Humectador-aromatizador. | |
ES1014067Y (es) | Caja-expositor. | |
ES1014804Y (es) | Auto-caravana independizable. | |
ES1019974Y (es) | Capazo-cuna. | |
ES1017193Y (es) | Cubre-bidet. | |
ES1015228Y (es) | Kiosko. | |
ES1015089Y (es) | Muneco caricatura titere. | |
ES1015059Y (es) | Capsula-tapa. |